Seeking Alpha

UnitedHealth (UNH) issues a report (.pdf) on the potential of genetic testing that indicates the...

UnitedHealth (UNH) issues a report (.pdf) on the potential of genetic testing that indicates the industry could grow to $25B annually - after the technology only generated $5B in 2010. Leerink Swann analyst Daniel Leonard tips off Genomic Health (GHDX) and Myriad Genetics (MYGN) as two companies that could benefit from a surge in the tests used to detect cancers and infectious diseases.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|